NEW BRUNSWICK, N.J., Jan. 4 /PRNewswire/ -- The recent emergence of many non-BIG PHARMA companies with profitable bottom lines while others are just launching their first products has caused a stir in the industry long dominated by companies with billion dollar drugs and worldwide marketing muscle. The advent of new, smaller companies is a major development whose influence on the marketplace will continue to grow.
Strategic Research Institute is pleased to announce the inaugural “Emerging & Early-Stage Pharma Marketing & Sales”, a two day conference featuring presenters from the many such companies.
The conference is but one of the 6 concurrent marketing meeting tracks that will take place as part of the “4th Annual Pharmaceutical Marketing & Sales Summit” (PMS), a two-day conference extravaganza offering conference sessions and unparalleled networking on April 4-5 in New Jersey.
Among the topics to be featured at the “Emerging & Early-Stage Pharma Marketing & Sales” include the following:
Pre-Launch Marketing: Next Generation in Product Commercialization Navigating the Regulatory Gauntlet Developing Successful Early-Stage Commercialization and Portfolio Management Pre- and Post-Launch Strategies for Rapid Product Uptake & Market Penetration Early-Stage Pharmaceutical Marketing: Global Budgets, Staffing & Resource Allocations Enhancing Pharma Marketing & Sales Strategies for Emerging & Specialty Pharmaceutical Companies
The inaugural conference focuses on the needs of emerging companies, many of which have never launched their own drugs and have stories to tell as well as additional information to seek. Lacking the human and capital resources of Big Pharma they are thus forced to devise creative ways to achieve their commercial goals.
Just a few of the HUNDREDS of companies comprising this market sector are Gilead Sciences, MedImmune, EyeTech, Valeant Pharmaceuticals, BiogenIdec, Genzyme, ICOS, Forest Labs, Indevus, Abgenix, Genta, Santarus, Sepracor, Cephalon, Celgene, plus branded generics firms.
To request the agenda or to apply for one of the few remaining speaking and panel slots, contact the organizer, Mark Alexay, Executive Vice President, Life Sciences, Strategic Research Institute at malexay@srinstitute.com or 212.967.0095, extension 251. Speaker proposals may be made until January 6.
The exposition hall is a great place to meet prospective clients and showcase one’s business in front of hundreds of Pharma attendees. Excellent sponsorship opportunities and exhibit space still remain. Contact Mark Alexay at malexay@srinstitute.com or 212.967.0095, extension 251 to determine what level of participation works best for you.
Strategic Research Institute
CONTACT: Mark Alexay, +1-212-967-0095, ext. 251, malexay@srinstitute.com
Web site: http://www.srinstitute.com//